Pyrazinamide

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 6336 publications

Real-world challenges of 4-month rifapentine-moxifloxacin TB regimen: High hyperbilirubinemia in Thailand.

Real-world challenges of 4-month rifapentine-moxifloxacin TB regimen: High hyperbilirubinemia in Thailand.

Journal: Journal of clinical tuberculosis and other mycobacterial diseases

Published: June 22, 2026

Epidemiology of extrapulmonary tuberculosis, Alameda County, California, 2010-2021.

Epidemiology of extrapulmonary tuberculosis, Alameda County, California, 2010-2021.

Journal: Journal of clinical tuberculosis and other mycobacterial diseases

Published: June 19, 2026

Chinese guideline for the chemotherapy of multidrug-resistant/rifampicin-resistant tuberculosis (2026 edition)

Chinese guideline for the chemotherapy of multidrug-resistant/rifampicin-resistant tuberculosis (2026 edition)

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Published: June 03, 2026

Bone tuberculosis in the distal metaphysis of a child's radius: case report.

Bone tuberculosis in the distal metaphysis of a child's radius: case report.

Journal: Acta ortopedica mexicana

Published: May 26, 2026

Adverse drug reactions to the nine-month all-oral and 18-month regimens for multidrug-resistant tuberculosis in Indonesia.

Adverse drug reactions to the nine-month all-oral and 18-month regimens for multidrug-resistant tuberculosis in Indonesia.

Journal: The International journal of risk & safety in medicine

Published: May 21, 2026

Effects of mutations conferring pyrazinamide resistance among multidrug-resistant tuberculosis isolates from China.

Effects of mutations conferring pyrazinamide resistance among multidrug-resistant tuberculosis isolates from China.

Journal: Microbiology spectrum

Published: May 20, 2026

Mtb-Timer: a fluorescent reporter to visualize Mycobacterium tuberculosis replication and antibiotic responses.

Mtb-Timer: a fluorescent reporter to visualize Mycobacterium tuberculosis replication and antibiotic responses.

Journal: mSystems

Published: May 19, 2026

In vitro antimicrobial resistance properties of rifapentine and rifampicin are indistinguishable.

In vitro antimicrobial resistance properties of rifapentine and rifampicin are indistinguishable.

Journal: Microbiology spectrum

Published: May 18, 2026

A randomised comparison of management strategies for drug-induced liver injury associated with tuberculous meningitis treatment.

A randomised comparison of management strategies for drug-induced liver injury associated with tuberculous meningitis treatment.

Journal: The Journal of infection

Published: May 14, 2026

Dual human lung models reveal compartment-specific activity of anti-tuberculosis drugs and host-directed therapies.

Dual human lung models reveal compartment-specific activity of anti-tuberculosis drugs and host-directed therapies.

Journal: Microbiology spectrum

Published: May 11, 2026

Computational Toxicology Analysis of Candidate Drivers and Pathways in HRZE-Associated Drug-Induced Liver Injury.

Computational Toxicology Analysis of Candidate Drivers and Pathways in HRZE-Associated Drug-Induced Liver Injury.

Journal: Toxicology mechanisms and methods

Published: May 11, 2026

Identification and drug resistance profiling of Mycobacterium orygis from an African elephant using whole-genome sequencing.

Identification and drug resistance profiling of Mycobacterium orygis from an African elephant using whole-genome sequencing.

Journal: Microbiology spectrum

Published: May 07, 2026

Showing 1-12 of 6,336

Last Updated: 06/30/2026